MedPath

MINOXIDIL 7% / PROGESTERONE 0.1% / TRETINOIN 0.025%

MINOXIDIL 7% / PROGESTERONE 0.1% / TRETINOIN 0.025%

Approved
Approval ID

883a3678-fea4-2d24-e053-2995a90a0666

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 6, 2019

Manufacturers
FDA

Sincerus Florida, LLC

DUNS: 080105003

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

MINOXIDIL 7% / PROGESTERONE 0.1% / TRETINOIN 0.025%

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code72934-4149
Product Classification
G
Generic Name
MINOXIDIL 7% / PROGESTERONE 0.1% / TRETINOIN 0.025%
Product Specifications
Route of AdministrationTOPICAL
Effective DateMay 6, 2019
FDA Product Classification

INGREDIENTS (3)

PROGESTERONEActive
Quantity: 0.1 g in 100 g
Code: 4G7DS2Q64Y
Classification: ACTIB
MINOXIDILActive
Quantity: 7 g in 100 g
Code: 5965120SH1
Classification: ACTIB
TRETINOINActive
Quantity: 0.025 g in 100 g
Code: 5688UTC01R
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

MINOXIDIL 7% / PROGESTERONE 0.1% / TRETINOIN 0.025% - FDA Drug Approval Details